NORGES BANK - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 239 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q4 2022$39,872,386
+44.5%
711,118
+9.1%
0.01%
+42.9%
Q3 2022$27,599,319
-17.8%
651,542
+4.8%
0.01%
-22.2%
Q2 2022$33,592,882
-20.1%
621,745
-5.0%
0.01%0.0%
Q1 2022$42,067,552
-7.1%
654,646
-3.2%
0.01%0.0%
Q4 2021$45,302,000
+44.7%
676,254
+48.0%
0.01%
+28.6%
Q3 2021$31,299,000
-34.5%
457,056
-34.8%
0.01%
-30.0%
Q2 2021$47,808,000
-1.9%
700,581
-0.6%
0.01%
-9.1%
Q1 2021$48,716,000
+5.2%
705,112
-1.1%
0.01%0.0%
Q4 2020$46,303,000
+56.0%
713,230
+13.5%
0.01%
+37.5%
Q3 2020$29,674,000
-15.1%
628,413
-15.5%
0.01%
-20.0%
Q2 2020$34,946,000
+6.5%
743,686
+1.3%
0.01%
-16.7%
Q1 2020$32,810,000
-22.3%
734,491
+1.4%
0.01%0.0%
Q4 2019$42,202,000
-3.0%
724,1310.0%0.01%
-7.7%
Q3 2019$43,498,000
+8.8%
724,131
+1.1%
0.01%
+8.3%
Q2 2019$39,991,000
-2.5%
716,042
-2.7%
0.01%
-7.7%
Q1 2019$41,006,000
+27.6%
735,936
+3.3%
0.01%
+8.3%
Q4 2018$32,141,000
-31.5%
712,6640.0%0.01%
-20.0%
Q3 2018$46,944,000
+2.3%
712,6640.0%0.02%
-6.2%
Q2 2018$45,903,000
+49.1%
712,664
+28.1%
0.02%
+45.5%
Q1 2018$30,793,000
+22.2%
556,434
+5.7%
0.01%
+22.2%
Q4 2017$25,201,000
-6.0%
526,569
-0.8%
0.01%
-10.0%
Q3 2017$26,801,000
+1.5%
530,916
+9.6%
0.01%0.0%
Q2 2017$26,396,000
+58.3%
484,241
+22.4%
0.01%
+42.9%
Q1 2017$16,672,000
-47.5%
395,723
+6.9%
0.01%
-50.0%
Q4 2016$31,772,000
-21.3%
370,344
-27.7%
0.01%
-26.3%
Q3 2016$40,364,000
+0.8%
511,950
+2.0%
0.02%0.0%
Q2 2016$40,046,000
+7.2%
501,950
-9.5%
0.02%
+5.6%
Q1 2016$37,348,000
-0.6%
554,4570.0%0.02%
-5.3%
Q4 2015$37,581,000
+65.0%
554,457
+45.0%
0.02%
+58.3%
Q3 2015$22,771,000
+6.6%
382,377
+20.6%
0.01%
+9.1%
Q2 2015$21,368,000
+9.3%
317,1770.0%0.01%
+10.0%
Q1 2015$19,554,000
+26.4%
317,177
+11.1%
0.01%
+25.0%
Q4 2014$15,476,000
+54.9%
285,377
+41.8%
0.01%
+60.0%
Q3 2014$9,994,000
-47.3%
201,317
-50.0%
0.01%0.0%
Q2 2014$18,948,000
+104.6%
402,634
+100.0%
0.01%0.0%
Q1 2014$9,259,000
-3.6%
201,3170.0%0.01%
-16.7%
Q4 2013$9,605,000
+18.5%
201,3170.0%0.01%
+20.0%
Q3 2013$8,103,000
+48.7%
201,317
+35.3%
0.01%
+66.7%
Q2 2013$5,451,000
+48.9%
148,816
+58.5%
0.00%
+50.0%
Q1 2013$3,662,000
-5.1%
93,8660.0%0.00%
-33.3%
Q3 2012$3,858,000
+6.9%
93,8660.0%0.00%0.0%
Q2 2012$3,610,00093,8660.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q3 2020
NameSharesValueWeighting ↓
Endurant Capital Management LP 281,608$13,298,0003.93%
Sapience Investments, LLC 266,915$12,604,0002.24%
Tributary Capital Management, LLC 514,305$24,285,0002.10%
Champlain Investment Partners, LLC 6,271,020$296,118,0002.01%
COOKE & BIELER LP 2,466,230$116,455,0001.55%
Hood River Capital Management LLC 474,531$22,407,0000.97%
Mitsubishi UFJ Asset Management (UK) Ltd. 18,400$869,0000.43%
GW&K Investment Management, LLC 624,102$29,470,0000.39%
Olstein Capital Management, L.P. 43,000$2,030,0000.37%
Loveless Wealth Management LLC 7,545$356,0000.30%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders